Intranasal 17β-estradiol treatment and Vitamin B12, folate and homocysteine in menopause

Conclusion: The reduction in plasma homocysteine levels observed after 6 months' treatment with intranasal 17β-estradiol may reflect an alteration in folate and Vitamin B12 homeostasis.